ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.524
+0.006 (1.22%)
At close: Dec 20, 2024, 4:00 PM
0.500
-0.024 (-4.52%)
After-hours: Dec 20, 2024, 5:46 PM EST
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $6.42 million as of December 20, 2024. Its market cap has decreased by -28.71% in one year.
Market Cap
6.42M
Enterprise Value
8.95M
1-Year Change
-28.71%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $6.42M, a decrease of -91.93%. That is a compound annual growth rate of -52.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 6.80M | -19.05% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Portage Biotech | 6.68M |
| Xenetic Biosciences | 6.62M |
| GRI Bio | 6.61M |
| Syra Health | 6.58M |
| Plus Therapeutics | 6.43M |
| PAVmed | 6.39M |
| Ainos | 6.24M |
| CNS Pharmaceuticals | 6.21M |